DEVELOPING · Attributed source report · science · World

Trial results posted: A Study of Androgen Annihilation in High-Risk Biochemically Relapsed Prostate Cancer

NULLPEN · Source published 11/9/2026, 12:00:00 AM UTC

ClinicalTrials.gov records the first posting of results for study NCT03009981 on 2026-11-09. A registry posting does not establish that a treatment is effective or safe.

Why it matters

New trial results are available for scrutiny. This report describes the posting only; it does not evaluate the findings.

What remains uncertain

The study findings have not been independently assessed by NULLPEN.

The source record

National Library of Medicine, National Institutes of Health

Source: ClinicalTrials.gov, National Library of Medicine, United States. Registry entries are filed by trial sponsors; the registry does not verify them.Retrieved 2026-11-09T18:20:26.647Z. Updated on NULLPEN 2026-11-09T18:20:28.833Z.Revision sha256:e28a158e2e322308c1e50681d0c35ec202abca95de165345ca984a7053b732ff